| Name | Big Y Pharmacy #23 |
|---|---|
| Organization Name | Big Y Foods Inc |
| Location | 200 West St, Pittsfield, Massachusetts 01201 |
| Type | Pharmacy |
| Phone | (413) 447-9844 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The biggest study into the treatment of urinary incontinence with botulinum toxin (trade name Botox) has demonstrated that it is effective in treating overactive bladder (OAB) - a debilitating common condition which can affect up to 20% of people over the age of 40.
The increased consumption of glucose that tumour cells exhibit, was thought to be a cause of the extra demand of building blocks required to keep up with an uncontrolled cell growth, but now it is more accepted that it could be the effect of a programmed metabolic change that favours this malignant growth.
The Community Living Assistance Services and Supports Act program, a provision of the health reform law, "establishes a voluntary, long-term care program that will provide cash to enrollees who suffer at least two limitations in daily activities, such as eating, bathing and dressing. … There are about 10 million Americans who need long-term care services, including 4 million under age 65."
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
› Verified 4 days ago
| NPI Number | 1487743019 |
| Organization Name | BIG Y FOODS INC |
| Doing Business As | BIG Y PHARMACY #23 |
| Type | Pharmacy |
| Address | 200 West St, Pittsfield, MA 01201 |
| Phone Number | 413-447-9844 |
News Archive
The biggest study into the treatment of urinary incontinence with botulinum toxin (trade name Botox) has demonstrated that it is effective in treating overactive bladder (OAB) - a debilitating common condition which can affect up to 20% of people over the age of 40.
The increased consumption of glucose that tumour cells exhibit, was thought to be a cause of the extra demand of building blocks required to keep up with an uncontrolled cell growth, but now it is more accepted that it could be the effect of a programmed metabolic change that favours this malignant growth.
The Community Living Assistance Services and Supports Act program, a provision of the health reform law, "establishes a voluntary, long-term care program that will provide cash to enrollees who suffer at least two limitations in daily activities, such as eating, bathing and dressing. … There are about 10 million Americans who need long-term care services, including 4 million under age 65."
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
› Verified 4 days ago
News Archive
The biggest study into the treatment of urinary incontinence with botulinum toxin (trade name Botox) has demonstrated that it is effective in treating overactive bladder (OAB) - a debilitating common condition which can affect up to 20% of people over the age of 40.
The increased consumption of glucose that tumour cells exhibit, was thought to be a cause of the extra demand of building blocks required to keep up with an uncontrolled cell growth, but now it is more accepted that it could be the effect of a programmed metabolic change that favours this malignant growth.
The Community Living Assistance Services and Supports Act program, a provision of the health reform law, "establishes a voluntary, long-term care program that will provide cash to enrollees who suffer at least two limitations in daily activities, such as eating, bathing and dressing. … There are about 10 million Americans who need long-term care services, including 4 million under age 65."
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
› Verified 4 days ago
Berkshire Community Pharmacy Type: Community/Retail Pharmacy Location: 725 North St, Pittsfield, Massachusetts 01201 Phone: (413) 395-7610 | |
Cvs Pharmacy # 00257 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 107 West Street, Pittsfield, Massachusetts 01201 Phone: (413) 499-4624 | |
Walgreens#17226 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 501 North St, Pittsfield, Massachusetts 01201 Phone: (413) 499-5411 | |
Walgreens#18122 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 37 Cheshire Rd, Pittsfield, Massachusetts 01201 Phone: (413) 443-4486 | |
T & C Flynns Pharmacy Inc Type: Medicare Supplier Location: 173 Elm St, Pittsfield, Massachusetts 01201 Phone: (413) 443-3219 |